While i thank
@Mozzarc for his erudite coverage of all the related possibilities of the application of iPPS, PAR board need to focus on just 1 avenue of applicability to NDA which is the 2mg dose for knee OA and the convincing supporting statistics required from the readout of phase III, and beyond..
To get there we need funding.
No amount of PR embellishment of "no deal yet but believe", somehow implies a real deal soon, only reinforces that PR is a dreamer, whose dream may come true, but he has been implying that ("soon") for a long time. Meanwhile, let me remind us all, we need money now. There is less than $25m in kitty, and the trial will eat that up in 3 months or so, certainly before the end of the year, now that patients are enrolling.
So where are we on a deal. Some small nation ? Think maybe SK, "we have been there <a lot> recently " or something similar.
An EGM, to approve placing some shares (but not enough to get to when the options expire).
Any sign of a convertible note or similar (hinted at but never done), well not yet -- in the absence of a deal, that is absolutely necessary.
IMO, without clear funding by the date PAROA options expire, it is over for PAR SH and it will be a cheap takeover. I urge SH to write to the Board members and say get on with funding directly, as in less far out than imminent
.
IMO. DYOR.
(20min delay)